ARV tax break call from Nigerian industry group

5 August 2007

The Nigerian Manufacturers Association, which includes a pharmaceutical sector representative group, has called for the establishment of a tax credit for the production of antiretroviral drugs in the west African country, the Vanguard of Nigeria reports. The industry body also announced the imminent launch of a national HIV/AIDS workplace policy for its members.

Chief Joe Ifejika, the NAM's director of field services, told the Vanguard that the group was working with Nigeria's National Agency for the Control of AIDS on developing HIV testing and workplace policies for HIV positive staff. He described the tax rebate for ARVs as a way of "appreciating" the efforts of local drugmakers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight